The Novo Nordisk Foundation is building a quantum chip fabrication plant in Copenhagen, with a reported investment of about $62 million. The project, carried out by Quantum Foundry Copenhagen, involves a 5,300-square-metre facility that is scheduled to open in 2027 and aims to provide wafer fabrication services for quantum technology companies.
Both outlets describe the effort as part of a broader global push toward quantum computing and related manufacturing capabilities. Rather than focusing on building a quantum computer, the planned plant concentrates on producing and processing quantum chips. Bloomberg frames the move in terms of intensifying international competition for the emerging technology, while The Next Web emphasizes the facility’s role in supplying fabrication capacity to companies worldwide.
The Foundation, which controls Novo Nordisk A/S (the maker of Ozempic), is backing the initiative through the Copenhagen-based quantum fabrication venture, positioning the site as a dedicated manufacturing hub for quantum hardware development.
